SEC Form 4 · accession 0001179110-17-007917

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President & CEO · Director

Period of report

May 22, 2017

Accepted (ET)

May 24, 2017 · 4:51 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 22, 2017	M	4,700	$1.07	A	822,961	D
Common Stock^F2	May 22, 2017	S	4,700	$29.58	D	818,261	D
Common Stock	May 23, 2017	M	9,700	$1.07	A	827,961	D
Common Stock^F3	May 23, 2017	S	9,700	$29.56	D	818,261	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$1.07	May 22, 2017	M	4,700	D	—	Apr 16, 2022	Common Stock	4,700	225,327	D
Employee Stock Option (right to buy)^F4	$1.07	May 23, 2017	M	9,700	D	—	Apr 16, 2022	Common Stock	9,700	215,627	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017.
F2Represents the weighted average price of transactions ranging from $29.55 to $29.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Represents the weighted average price of transactions ranging from $29.55 to $29.63. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The options vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016.